Related Experiment Video
Updated: Jun 17, 2025
Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
Published on: October 25, 2011
The unveiled mosaic of intra-tumor heterogeneity in ovarian cancer through spatial transcriptomic technologies: A
Laura Masatti1, Matteo Marchetti2, Stefania Pirrotta1
1Department of Biology, University of Padova, Padova, Italy.
Abstract:
Epithelial ovarian cancer is a significant global health issue among women. Diagnosis and treatment pose challenges due to difficulties in predicting patient responses to therapy, primarily stemming from gaps in understanding tumor chemoresistance mechanisms. Recent advancements in transcriptomic technologies like single-cell RNA sequencing and spatial transcriptomics have greatly improved our understanding of ovarian cancer intratumor heterogeneity and tumor microenvironment composition. Spatial transcriptomics, in particular, comprises a plethora of technologies that enable the detection of hundreds of transcriptomes and their spatial distribution within a histological section, facilitating the study of cell types, states, and interactions within the tumor and its microenvironment. Studies investigating the spatial distribution of gene expression in ovarian cancer masses have identified specific features that impact prognosis and therapy outcomes. Emerging evidence suggests that specific spatial patterns of tumor cells and their immune and non-immune microenvironment significantly influence therapy response, as well as the behavior and progression of primary tumors and metastatic sites. The importance of spatially contextualizing ovarian cancer transcriptomes is underscored by these findings, which will advance our understanding and therapeutic approaches for this complex disease.
Insights
Spatial transcriptomics reveals how ovarian cancer cell patterns and their microenvironment impact treatment response and disease progression. Understanding these spatial features is key to improving therapies for this women
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Epithelial ovarian cancer presents significant global health challenges.
- Predicting patient response to therapy is difficult due to incomplete understanding of tumor chemoresistance.
- Recent transcriptomic technologies have enhanced insights into ovarian cancer heterogeneity and microenvironment.
Purpose of the Study:
- To explore the role of spatial transcriptomics in understanding ovarian cancer.
- To investigate how spatial gene expression patterns influence prognosis and therapy outcomes.
- To highlight the importance of spatial context in ovarian cancer research.
Main Methods:
- Utilizing advanced transcriptomic technologies, including single-cell RNA sequencing and spatial transcriptomics.
- Analyzing the spatial distribution of hundreds of transcriptomes within ovarian cancer histological sections.
- Investigating cell types, states, and interactions within the tumor and its microenvironment.
Main Results:
- Spatial transcriptomics enables detailed study of cell composition and interactions in ovarian cancer.
- Specific spatial patterns of tumor cells and microenvironment components correlate with prognosis and therapy response.
- Spatial gene expression features impact primary tumor and metastatic site behavior.
Conclusions:
- Spatial transcriptomics is crucial for deciphering ovarian cancer intratumor heterogeneity and microenvironment.
- Understanding spatial transcriptomic data advances knowledge of therapy response and disease progression.
- Spatially contextualized transcriptomic analysis promises improved therapeutic strategies for ovarian cancer.
